Quality Metrics and the Link to Operational Excellence Whitepaper

Mike Florence and John Seagrief

The FDA is driving the development of a culture of quality across the pharmaceutical industry. Currently, they request the voluntary submission of summary ‘Quality Metrics’ (QMs). This request is likely to become a requirement in 2018.

Linking QMs to performance indicators across an organisation will drive focused improvement initiatives, delivering process and supply chain robustness. As a result, this will lead to reduced quality issues, reduced costs and increased profitability. In addition, Quality and Operations executives will have more time to work on strategy rather than day-to-day problem solving.